Clincosm LogoSign in Get a demo

Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection

Sponsor
Guangdong Provincial People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05586035
Collaborator
The People's Hospital of Gaozhou (Other), Shenzhen People's Hospital (Other)
300
Enrollment
1
Location
23.9
Anticipated Duration (Months)
12.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Surgical resection is the primary treatment for pulmonary tumors. Surgeons has been frequently concerned about effectiveness, safety, and minimal invasive techniques. However, persistent cough, one of the most common complications of lung surgery, has received insufficient attention. This study set out to investigate the risk factors and treatment related to persistent cough after pulmonary resection.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection
    Actual Study Start Date :
    Sep 2, 2021
    Anticipated Primary Completion Date :
    Dec 30, 2022
    Anticipated Study Completion Date :
    Aug 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Occurence rate of persistent cough after pulmonary resection [Persistent cough after pulmonary resection is monitored from the time of surgery, up to 12 months.]

      Occurence rate of persistent cough after pulmonary resection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    1. Patients who received pulmonary resection;

    2. 18-to 85-year-old;

    3. Pathologically diagnosed as NSCLC or benign tumor.

    Exclusion Criteria:

    1. Multiple malignancy in other parts of body;

    2. Refuse to participate in this study;

    3. Other situations evaluated by investigators not meet the enrollment.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Guangdong Provincial People's Hospital Guangzhou Guangdong China 510080

    Sponsors and Collaborators

    • Guangdong Provincial People's Hospital
    • The People's Hospital of Gaozhou
    • Shenzhen People's Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Guangdong Provincial People's Hospital
    ClinicalTrials.gov Identifier:
    NCT05586035
    Other Study ID Numbers:
    • KY-Q-2022-007
    First Posted:
    Oct 19, 2022
    Last Update Posted:
    Oct 19, 2022
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Lung Neoplasms
    Cough

    Study Results

    No Results Posted as of Oct 19, 2022